These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885 [TBL] [Abstract][Full Text] [Related]
49. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development. Negus SS; Banks ML Pharmacol Biochem Behav; 2018 Jan; 164():32-39. PubMed ID: 28442370 [TBL] [Abstract][Full Text] [Related]
50. Community reinforcement therapy for cocaine-dependent outpatients. Higgins ST; Sigmon SC; Wong CJ; Heil SH; Badger GJ; Donham R; Dantona RL; Anthony S Arch Gen Psychiatry; 2003 Oct; 60(10):1043-52. PubMed ID: 14557150 [TBL] [Abstract][Full Text] [Related]
51. Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program. Bornovalova MA; Daughters SB; Hernandez GD; Richards JB; Lejuez CW Exp Clin Psychopharmacol; 2005 Nov; 13(4):311-8. PubMed ID: 16366761 [TBL] [Abstract][Full Text] [Related]
52. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement. Sigmon SC; Correia CJ; Stitzer ML Exp Clin Psychopharmacol; 2004 Nov; 12(4):269-75. PubMed ID: 15571444 [TBL] [Abstract][Full Text] [Related]
53. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. Shoptaw S; Yang X; Rotheram-Fuller EJ; Hsieh YC; Kintaudi PC; Charuvastra VC; Ling W J Clin Psychiatry; 2003 Dec; 64(12):1440-8. PubMed ID: 14728105 [TBL] [Abstract][Full Text] [Related]
54. Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users. Lejuez CW; Bornovalova MA; Daughters SB; Curtin JJ Drug Alcohol Depend; 2005 Feb; 77(2):169-75. PubMed ID: 15664718 [TBL] [Abstract][Full Text] [Related]
56. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Preston KL; Silverman K; Schuster CR; Cone EJ Addiction; 1997 Jun; 92(6):717-27. PubMed ID: 9246799 [TBL] [Abstract][Full Text] [Related]
57. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Gonzalez G; Sevarino K; Sofuoglu M; Poling J; Oliveto A; Gonsai K; George TP; Kosten TR Addiction; 2003 Nov; 98(11):1625-32. PubMed ID: 14616189 [TBL] [Abstract][Full Text] [Related]
58. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144 [TBL] [Abstract][Full Text] [Related]
59. The impact of benzodiazepine use on methadone maintenance treatment outcomes. Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528 [TBL] [Abstract][Full Text] [Related]
60. A comparative study of cocaine-treatment completers and dropouts. McMahon RC; Kouzekanani K; Malow RM J Subst Abuse Treat; 1999 Jan; 16(1):17-22. PubMed ID: 9888117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]